Nuclear Medicine

Pediatric Hematology/Oncology

Questions discussed in this category

How do you interpret a Deauville score of 3 on PET when performing mid-treatment assessments in patients with Hodgkin lymphoma?

Are there situations in which a Deauville 3 would cause you to escalate therapy?

2 Answers available

Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-09-20

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Blood, 2016-11-24

Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy.

Lancet, 2012 Apr 04

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

Blood, 2018 Aug 30

Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma.

Related Topics in Nuclear Medicine